Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Role Of Serum Glypican 3 As A Predictive Tool For Early Diagnosis Of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma Detection in Hepatitis C Virus-Related Cirrhosis by Glypican-3

Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

A STUDY OF GLYPICAN 3 LEVELS IN PATIENTS OF HEPATO-CELLULAR CARCINOMA

A COMPARATIVE STUDY OF THE DIAGNOSTIC AND PROGNOSTIC VALUE OF GOLGI PROTEIN 73 AND ALFA-FETO PROTEIN IN HEPATOCELLULAR CARCINOMA BEFORE AND AFTER THERAPEUTIC INTERVENTION

ROLE OF SERUM GLYPICAN-3 (GPC-3) IN EARLY DETECTION OF HEPATOCELLULAR CARCENOMA

VALUE OF SERUM ALPHA L FUCOSIDASE LEVEL AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA BEFORE AND AFTER CHEMO-EMBOLIZATION AND RADIO-FREQUENCY, A PROSPECTIVE STUDY

PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA

Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients